Aspects of healthcare utilisation in self-reported obstructive lung disease

Clinical Respiratory Journal

Volumn 3, Issue 1, 2009, Pages 34-41

  Nielsen, Rune ^a,b   Johannessen, Ane ^b   Bakke, Per Sigvald ^a,b   Askildsen, Jan Erik ^a   Omenaas, Ernst Reidar ^a,b   Gulsvik, Amund ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Determinants of utilisation; Health resources utilisation; Healthcare surveys; Obstructive lung diseases; Respiratory function tests; Respiratory symptoms

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE UTILIZATION; HEALTH SERVICE; HEALTH SURVEY; HOSPITAL ADMISSION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; PENSION; POPULATION; PREDICTION; PRIORITY JOURNAL; SELF REPORT; SOCIAL WORK; SPIROMETRY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; COMMUNITY HEALTH SERVICES; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES; HEALTH SERVICES ACCESSIBILITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NORWAY; PATIENT ACCEPTANCE OF HEALTH CARE; PROBABILITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RISK FACTORS; SELF DISCLOSURE; SEVERITY OF ILLNESS INDEX; SOCIAL WORK; SOCIOECONOMIC FACTORS; SPIROMETRY; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 68849120880     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/j.1752-699X.2008.00106.x     Document Type: Article

References (30)

1. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of COPD - 2006 update. Am J Respir Crit Care Med. 2007 176 : 532 55.
2. Accordini S, Bugiani M, Arossa W, et al. Poor control increases the economic cost of asthma. A multicentre population-based study. Int Arch Allergy Immunol. 2006 141 : 189 98.
3. Van Ganse E, Antonicelli L, Zhang Q, Laforest L, Yin DD, Nocea G, Sazonov Kocevar V. Asthma-related resource use and cost by GINA classification of severity in three European countries. Respir Med. 2006 100 : 140 7.
4. Miravitlles M, Murio C, Guerrero T, Gisbert R. Costs of chronic bronchitis and COPD: a 1-year follow-up study. Chest. 2003 123 : 784 91.
5. Bilde L, Rud Svenning A, Dollerup J, Baekke Borgeskov H, Lange P. The cost of treating patients with COPD in Denmark - a population study of COPD patients compared with non-COPD controls. Respir Med. 2007 101 : 539 46.
6. Jansson SA, Andersson F, Borg S, Ericsson A, Jonsson E, Lundback B. Costs of COPD in Sweden according to disease severity. Chest. 2002 122 : 1994 2002.
7. Wouters EFM. Economic analysis of the confronting COPD survey: an overview of results. Respir Med. 2003 97 : S3 14.
8. Miravitlles M, de la Roza C, Morera J, Montemayor T, Gobartt E, Martin A, Alvarez-Sala JL. Chronic respiratory symptoms, spirometry and knowledge of COPD among general population. Respir Med. 2006 100 : 1973 80.
9. Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest. 2003 124 : 474 81.
10. Miller JD, Foster T, Boulanger L, Chace M, Russell MW, Marton JP, Menzin J. Direct costs of COPD in the U.S.: an analysis of Medical Expenditure Panel Survey (MEPS) data. Copd. 2005 2 : 311 18.
11. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2007. Available from http://www.ginasthma.org.
12. Johannessen A, Omenaas ER, Bakke PS, Gulsvik A. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax. 2005 60 : 842 7.
13. ECRHS II. Protocol for the European Community Respiratory Health Survey II. London, King's College, 2003.
14. Brogger J, Bakke P, Eide GE, Gulsvik A. Comparison of telephone and postal survey modes on respiratory symptoms and risk factors. Am J Epidemiol. 2002 155 : 572 6.
15. Frostad A, Soyseth V, Andersen A, Gulsvik A. Respiratory symptoms as predictors of all-cause mortality in an urban community: a 30-year follow-up. J Intern Med. 2006 259 : 520 9.
16. American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med. 1995 152 : 1107 36.
17. Johannessen A, Lehmann S, Omenaas ER, Eide GE, Bakke PS, Gulsvik A. Post-bronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med. 2006 173 : 1316 25.
18. Johannessen A. Obstructive pulmonary disease (COPD) in Western Norway - incidence, prevalence and spirometric reference values based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD). Dissertation, Bergen, Norway, University of Bergen, 2007.
19. Braman SS. The global burden of asthma. Chest. 2006 130 : 4S 12S.
20. Johannessen A, Omenaas E, Bakke P, Gulsvik A. Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. Int J Tuberc Lung Dis. 2005 9 : 926 32.
21. Raina P, Torrance-Rynard V, Wong M, Woodward C. Agreement between self-reported and routinely collected health-care utilization data among seniors. Health Serv Res. 2002 37 : 751 74.
22. Evans C, Crawford B. Patient self-reports in pharmacoeconomic studies. Their use and impact on study validity. Pharmacoeconomics. 1999 15 : 241 56.
23. Baker M, Stabile M, Deri C. What do self-reported, objective, measures of health measure? J Hum Resour. 2004 39 : 1067 93.
24. Accordini S, Corsico A, Cerveri I, et al. The socio-economic burden of asthma is substantial in Europe. Allergy. 2008 63 : 116 24.
25. Mapel DW, McMillan GP, Frost FJ, Hurley JS, Picchi MA, Lydick E, Spencer MD. Predicting the costs of managing patients with chronic obstructive pulmonary disease. Respir Med. 2005 99 : 1325 33.
26. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination. J Intern Med. 2003 254 : 540 7.
27. Frostad A, Soyseth V, Haldorsen T, Andersen A, Gulsvik A. Respiratory symptoms and 30 year mortality from obstructive lung disease and pneumonia. Thorax. 2006 61 : 951 6.
28. Voll-Aanerud M, Eagan TM, Wentzel-Larsen T, Gulsvik A, Bakke PS. Changes in respiratory symptoms and health-related quality of life. Chest. 2007 131 : 1890 7.
29. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004 23 : 932 46.
30. Statens Legemiddelverk. Astma og KOLS: endringer i blå reseptforskriften gyldig fra 1. July 2007. (In Norwegian) Available from http://www.legemiddelverket.no/templates/InterPage-31780.aspx.